Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Flatt, US
Austen K. Flatt, Sugar Land, TX US
| Patent application number | Description | Published |
|---|---|---|
| 20090042136 | Carbon Nanotube-Silicon Composite Structures and Methods for Making Same - The present invention is directed toward methods of attaching or grafting carbon nanotubes (CNTs) to silicon or other surfaces, wherein such attaching or grafting occurs via functional groups on either or both of the CNTs and silicon surface. The present invention is also directed to the novel compositions produced by such methods. Previous work by Applicants has demonstrated covalent attachment of arenes via aryldiazonium salts to Si (hydride passivated single crystal or poly Si; <111> or <100>, p-doped, n-doped or intrinsic), GaAs, and Pd surfaces. In the case of Si, this provides a direct arene-Si bond with no intervening oxide. Applicants have also reported on the use of aryldiazonium salts for the direct covalent linkage of arenes to single wall carbon nanotubes (SWNTs) where the nanotubes can exist either as bundles or individual structures (when surfactant-wrapped). In some embodiments, the present invention is directed to a merger of these two technologies to afford the covalent attachment of individualized (unroped) SWNTs to Si surfaces. | 02-12-2009 |
| 20110009556 | METHOD OF REDUCING THE VISCOSITY OF HYDROCARBON FLUIDS - A method for reducing the viscosity of a hydrocarbon fluid encountered in petroleum operations is disclosed. The method includes contacting the hydrocarbon fluid with an effective amount of a composition comprising at least one polymer having at least 25 mole percent cationic monomers. | 01-13-2011 |
Austen K. Flatt, Houston, TX US
| Patent application number | Description | Published |
|---|---|---|
| 20080260616 | Bulk Separation of Carbon Nanotubes by Bandgap - The present invention is directed to methods of separating carbon nanotubes (CNTs) by their electronic type (e.g., metallic, semi-metallic, and semiconducting). Perhaps most generally, in some embodiments, the present invention is directed to methods of separating CNTs by bandgap, wherein such separation is effected by interacting the CNTs with a surface such that the surface interacts differentially with the CNTs on the basis of their bandgap, or lack thereof. In some embodiments, such methods can allow for such separations to be carried out in bulk quantities. | 10-23-2008 |
Erick P. Flatt, Dallas, TX US
| Patent application number | Description | Published |
|---|---|---|
| 20080263751 | Perspiration Redirecting Head Band Device - A head band device for protecting a wearer's eyes from perspiration from the wearer's forehead is provided. A substantially nonabsorbent band includes a front band portion and two side band portions. The gutter structure extends from an outer surface of the band. The gutter structure includes a gutter base and a gutter lip. The gutter structure in combination with the front band portion and at least part of the first and second side band portions forms a perspiration channel with a generally U-shaped cross-section. The gutter base has a first thickness at a central portion thereof. The gutter base has a second thickness at end portions thereof. The first thickness is greater than the second thickness. The gutter base slopes from the central portion downward toward the end portions thereof, transitioning from the first thickness to the second thickness. A closure system has two fasteners and an elastic loop member. | 10-30-2008 |
James Flatt, Colorado Springs, CO US
| Patent application number | Description | Published |
|---|---|---|
| 20110112191 | OXYLIPINS FROM STEARIDONIC ACID AND GAMMA-LINOLENIC ACID AND METHODS OF MAKING AND USING SAME - Disclosed are novel oxylipins that are derived from γ-linolenic acid (GLA; 18:3n-6) and stearidonic acid (STA or SDA; 18:4n-3), and methods of making and using such oxylipins. Also disclosed is the use of such oxylipins in therapeutic and nutritional or cosmetic applications, and particularly as anti-inflammatory or anti-neurodegenerative compounds. Also disclosed are The invention novel ways of producing long chain polyunsaturated acid (LCPUFA)-rich oils and compositions that contain enhanced and effective amounts of SDA- and/or GLA-derived oxylipins. | 05-12-2011 |
| 20110178047 | Oxylipins From Long Chain Polyunsaturated Fatty Acids and Methods of Making and Using the Same - Disclosed are novel oxylipins, referred to herein as docosanoids, that are derived from C22 polyunsaturated fatty acids, and method of making and using such oxylipins. Also disclosed is the use of docosapentaenoic acid (C22:5n-6) (DPAn-6), docosapentaenoic acid (C22:5n-3) (DPAn-3), and docosatetraenoic acid (DTAn-6: C22:4n-6) as substrates for the production of novel oxylipins, and to the oxylipins produced thereby. Also disclosed is the use of DPAn-6, DPAn-3, DTAn-6, and/or the oxylipins derived therefrom, and/or novel docosanoids derived from the structures of C22 fatty acids, in therapeutic and nutritional or cosmetic applications, and particularly as anti-inflammatory or anti-neurodegenerative compounds. The invention also relates to novel ways of producing long chain polyunsaturated acid (LCPUFA)-rich oils and compositions that contain enhanced and effective amounts of LCPUFA-derived oxylipins, and particularly, docosanoids. | 07-21-2011 |
| 20110190389 | OXYLIPINS FROM LONG CHAIN POLYUNSATURATED FATTY ACIDS AND METHODS OF MAKING AND USING THE SAME - Disclosed are novel oxylipins, referred to herein as docosanoids and eicosanoids, that are derived from C22 polyunsaturated fatty acids and from C20 polyunsaturated fatty acids, respectively, and methods of making and using such oxylipins. Also disclosed is the use of docosapentaenoic acid (C22:5n-6) (DPAn-6), docosapentaenoic acid (C22:5n-3) (DPAn-3), and docosatetraenoic acid (DTAn-6: C22:4n-6), docosatrienoic acid (C22:3n-3) (DTrAn-3), docosadienoic acid (C22:2n-6) (DDAn-6), eicosatrienoic acid (C20:3n-3) (ETrAn-3) eicosapentaenoic acid and arachidonic acid as substrates for the production of novel oxylipins, and to the oxylipins produced thereby. Also disclosed is the use of DPAn-6, DPAn-3, DTAn-6, and/or the oxylipins derived therefrom, and/or novel docosanoids derived from the structures of C22 fatty acids in therapeutic and nutritional or cosmetic applications, and particularly as anti-inflammatory or anti-neurodegenerative compounds. The invention also relates to novel ways of producing long chain polyunsaturated acid (LCPUF A)-rich oils and compositions that contain enhanced and effective amounts of LCPUF A-derived oxylipins, and particularly, docosanoids. | 08-04-2011 |
James Flatt, Baltimore, MD US
| Patent application number | Description | Published |
|---|---|---|
| 20090320148 | OXYLIPINS FROM STEARIDONIC ACID AND GAMMA-LINOLENIC ACID AND METHODS OF MAKING AND USING THE SAME - Disclosed are novel oxylipins that are derived from γ-linolenic acid (GLA; 18:3n-6) and stearidonic acid (STA or SDA; 18:4n-3), and methods of making and using such oxylipins. Also disclosed is the use of such oxylipins in therapeutic and nutritional or cosmetic applications, and particularly as anti-inflammatory or anti-neurodegenerative compounds. Also disclosed are The invention novel ways of producing long chain polyunsaturated acid (LCPUF A)-rich oils and compositions that contain enhanced and effective amounts of SDA- and/or GLA-derived oxylipins. | 12-24-2009 |
James E. Flatt, Marshall, MI US
| Patent application number | Description | Published |
|---|---|---|
| 20100213310 | Shuttle Stop Force Limiter - The present invention provides an actuator characterized by the use of a shuttle that shifts in response to an overload. The shuttle is movable axially relative to a rotary input member by continued rotation of the rotary input member so that a stop on the shuttle moves from an ambush position allowing free rotation of the rotary input member to a blocking position preventing further rotation of the rotary input member. In this way, the shuttle can be used to prevent rotation of a rotary input member during an overload of a control surface, thereby preventing damage to the actuator. | 08-26-2010 |
James E. Flatt, Portage, MI US
| Patent application number | Description | Published |
|---|---|---|
| 20090289145 | ELECTROMECHANICAL ACTUATING ASSEMBLY - An electromechanical actuating assembly ( | 11-26-2009 |
James H. Flatt, Colorado Springs, CO US
| Patent application number | Description | Published |
|---|---|---|
| 20100024050 | PUFA POLYKETIDE SYNTHASE SYSTEMS AND USES THEREOF - The invention generally relates to polyunsaturated fatty acid (PUFA) polyketide synthase (PKS) systems isolated from or derived from non-bacterial organisms, to homologues thereof, to isolated nucleic acid molecules and recombinant nucleic acid molecules encoding biologically active domains of such a PUFA PKS system, to genetically modified organisms comprising PUFA PKS systems, to methods of making and using such systems for the production of bioactive molecules of interest, and to novel methods for identifying new bacterial and non-bacterial microorganisms having such a PUFA PKS system. | 01-28-2010 |
| 20100099154 | PUFA POLYKETIDE SYNTHASE SYSTEMS AND USES THEREOF - The invention generally relates to polyunsaturated fatty acid (PUFA) polyketide synthase (PKS) systems, to homologues thereof, to isolated nucleic acid molecules and recombinant nucleic acid molecules encoding biologically active domains of such a PUFA PKS system, to genetically modified organisms comprising PUFA PKS systems, to methods of making and using such systems for the production of bioactive molecules of interest, and to novel methods for identifying new bacterial and non-bacterial microorganisms having such a PUFA PKS system. | 04-22-2010 |
| 20110167508 | PUFA POLYKETIDE SYNTHASE SYSTEMS AND USES THEREOF - The invention generally relates to polyunsaturated fatty acid (PUFA) polyketide synthase (PKS) systems, to homologues thereof, to isolated nucleic acid molecules and recombinant nucleic acid molecules encoding biologically active domains of such a PUFA PKS system, to genetically modified organisms comprising PUFA PKS systems, to methods of making and using such systems for the production of bioactive molecules of interest, and to novel methods for identifying new bacterial and non-bacterial microorganisms having such a PUFA PKS system. | 07-07-2011 |
| 20110250342 | PUFA Polyketide Synthase Systems and Uses Thereof - Disclosed are the complete polyunsaturated fatty acid (PUFA) polyketide synthase (PKS) systems from | 10-13-2011 |
Jim Flatt, Colorado Springs, CO US
| Patent application number | Description | Published |
|---|---|---|
| 20110312054 | Isolation and Characterization of Schizochytrium Aggregatum Cellobiohydrolase I (CBH I) - The present invention provides for the isolation and characterization of the cbh1 gene from | 12-22-2011 |
Thomas Flatt, Summerville, SC US
| Patent application number | Description | Published |
|---|---|---|
| 20110209643 | Novel Crystal Forms of Quinacridones Made from 2,9-Dimethoxyquinacridone and 2,9-Dichloroquinacridone - Novel crystal forms of solid solutions of 2,9-dimethyoxyquinacridone and 2,9-dichloroquinacridone. The crystal forms may be formed by a process comprising the steps of: a) heating a mixture of 2,5-di(4-methoxyanilino)terephthalic acid, and 2,5-di(4-chloroanilino)terephthalic acid in polyphorsphoric acid at a temperature less than 1050 C to form a mixture of 2,9-dimethoxyquinacridone and 2,9-dichloroquinacridone; b) combining the mixture of 2,9-dimethoxyquinacridone and 2,9-dichloro-quinacridone with water; and c) heating the mixture of 2,9-dimethoxyquinacridone and 2,9-dichloroquinacridone at a temperature not more than 110° C. Another crystal form may be formed by the process of heating a mixture of 2,9-dimethoxyquinacridone and 2,9-dichloroquinacridone in a polar aprotic solvent. These products are may be used for coloring fibers, plastics, paints, coatings, printing inks, color filters, cosmetics, automotive coatings, textiles, fibers, powder coatings, in-mold coatings, laminate films, and the like. | 09-01-2011 |